Back to results
US 2008/0167368 A1Published application
Substituted Pyrroles, Compositions Containing Same, Method for Making Same and Use Thereof
AssigneeAventis Pharma S.A.
InventorsBaptiste RONAN, Michel TABART, Catherine SOUAILLE, Fabrice VIVIANI, Eric BACQUE, Jean-Philippe LETALLEC, Pascal DESMAZEAU
Life of this patent
Estimating the term…
Abstract
The disclosure concerns substituted pyrroles of formula (I): wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same and uses thereof, in particular as anti-cancer agents.
Claims25
A compound of formula (I):
- in which:
- 1) A and Ar are independently selected from the group consisting of:
- aryl, heteroaryl, heterocyclyl, substituted aryl, substituted heteroaryl, substituted heterocyclyl, cycloalkyl, and substituted cycloalkyl;
- 2) L is selected from the group consisting of:
- NH, CO—NH, NH—CO, NH—SO2, SO2NH, NH—CH2, CH2—NH, CH2—CO—NH, NH—CO—CH2, NH—CH2—CO, CO—CH2—NH, NH—CO—NH, NH—CS—NH, NH—CO—O, O—CO—NH, CH2—NH—CO—NH, NH—CO—NH—CH2, and NH—CO—CH2—CO—NH;
- 3) Ra is selected from the group consisting of H, alkyl and cycloalkyl;
- 4) R1 is selected from the group consisting of:
- H, R, COR, and SO2R, in which R is chosen from H, OR″4, NR″5R″6, (C1-C6)alkyl, cycloalkyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl, in which R″4 is chosen from H, phenyl, and alkyl, and in which R″5 and R″6 are independently selected from the group consisting of H, R OR″4, (C1-C6)alkyl, cycloalkyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, and substituted heteroaryl or alternatively R″5 and R″6 are linked to each other to form a 5- to 8-membered saturated ring containing from 0 to 3 heteroatoms chosen from O, S and N;
- 5) R2 and R5 are independently selected from the group consisting of:
- H, halogen, R′2, CN, O(R′2), OC(O)(R′2), OC(O)N(R′2)(R′3), OS(O2)(R′2), N(R′2)(R′3), N═C(R′2)(R′3), N(R′2)C(O)(R′3), N(R′2)C(O)O(R′3), N(R′4)C(O)N(R′2)(R′3), N(R′4)C(S)N(R′2)(R′3), N(R′2)S(O2)(R′3), C(O)(R′2), C(O)O(R′2), C(O)N(R′2)(R′3), C(═N(R′3))(R′2), C(═N(OR′3))(R′2), S(R′2), S(O)(R′2), S(O2)(R′2), S(O2)O(R′2), and S(O2)N(R′2)(R′3);
- in which each R′2, R′3, R′4 is independently selected from the group consisting of H, alkyl, alkylene, alkynyl, aryl, heteroaryl, cycloalkyl, heterocyclyl, substituted alkyl, substituted alkylene, substituted alkynyl, substituted aryl, substituted heteroaryl, substituted cycloalkyl, and substituted heterocyclyl;
- in which, when R′2 and R′3 are each different from H and simultaneously present on R2 or on R3, they may be linked to each other to form a ring containing from 0 to 3 heteroatoms chosen from O, S and N;
- or a pharmaceutically acceptable salt thereof.
10 more elements
Dependencies are inferred from the claim text.